Ryan Bruns
Acute Care · Nashville, TNNPI 1215793146
Payments from drug & device makers
Across 95 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$431
- Johnson & Johnson$202
- Madrigal Pharmaceuticals$169
- Aimmune Therapeutics, Inc.$153
- Ardelyx, Inc.$125
- Lilly USA, LLC$104
- plus $566 from 15 others
What the payments were for
- Food & beverage$1,65194%
- Education$996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $431 |
| Johnson & Johnson | 5 | $202 |
| Madrigal Pharmaceuticals | 9 | $169 |
| Aimmune Therapeutics, Inc. | 8 | $153 |
| Ardelyx, Inc. | 7 | $125 |
| Lilly USA, LLC | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Sanofi | 4 | $75 |
| Redhill Biopharma Inc. | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Gilead | 3 | $50 |
| Novo Nordisk | 2 | $41 |
| QOL Medical, LLC | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Pfizer | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Evoke Pharma, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Celltrion USA Inc. | 1 | $15 |
| Organon | 1 | $11 |
How this compares
$1,750 in reported general payments places this provider in the 80th percentile of 738 acute care providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 11 | $8,214 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 29 | $449 |
| Pantoprazole Sodium | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $431 | $8,21411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 738 acute care providers in Tennessee.
Other acute care in Nashville
- Haley HoyNashville$368K
- Shannon GraceNashville$57K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Elizabeth DavidsonNashville$33K
- Kathryn EstopinalNashville$25K
- Tisha BarzykNashville$23K
- Krista Kuhnert-GainerNashville$17K
- Donna SmithNashville$13K
- Amy CoxNashville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.